Ensysce Biosciences Inc ENSC

Alternate Symbol(s): ENSCW

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

NDAQ:ENSC - Post by User

Ensysce Biosciences Inc

<< Previous

Bullboard Posts

Next >>

(163)
•••

Post by Iseneschalon Apr 19, 2023 11:50am

92 Views

Post# 35403131

ENSC...... I guess that's all you get ; )

A big flash in the pan breakout to the H.O.D.....then it goes stone cold with volumes decreasing on the 5 min chart

Oh well.... I guess all the Frontloaders post RS have had their fun

On to the "Next One"

<< Previous

Bullboard Posts

Next >>

Almonty Industries goes NASDAQ: In the fast lane with one of the world's most critical metals